Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER

 
• By Sue Sutter
Walking in step
FDA's Peter Marks believes CBER and CDER will be walking in step more often going forward. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards